Cargando…
CITK Loss Inhibits Growth of Group 3 and Group 4 Medulloblastoma Cells and Sensitizes Them to DNA-Damaging Agents
Medulloblastoma (MB) is the most common malignant brain tumor in children, and it is classified into four biological subgroups: WNT, Sonic Hedgehog (SHH), Group 3 and Group 4. The current treatment is surgery, followed by irradiation and chemotherapy. Unfortunately, these therapies are only partiall...
Autores principales: | Pallavicini, Gianmarco, Iegiani, Giorgia, Berto, Gaia Elena, Calamia, Elisa, Trevisiol, Edoardo, Veltri, Andrea, Allis, Simona, Di Cunto, Ferdinando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139701/ https://www.ncbi.nlm.nih.gov/pubmed/32111106 http://dx.doi.org/10.3390/cancers12030542 |
Ejemplares similares
-
CENPE Inhibition Leads to Mitotic Catastrophe and DNA Damage in Medulloblastoma Cells
por: Iegiani, Giorgia, et al.
Publicado: (2021) -
Lestaurtinib inhibits Citron kinase activity and medulloblastoma growth through induction of DNA damage, apoptosis and cytokinesis failure
por: Pallavicini, Gianmarco, et al.
Publicado: (2023) -
Inhibiting microcephaly genes as alternative to microtubule targeting agents to treat brain tumors
por: Iegiani, Giorgia, et al.
Publicado: (2021) -
The impact of TP53 activation and apoptosis in primary hereditary microcephaly
por: Iegiani, Giorgia, et al.
Publicado: (2023) -
Precision Revisited: Targeting Microcephaly Kinases in Brain Tumors
por: Pallavicini, Gianmarco, et al.
Publicado: (2019)